Literature DB >> 27558823

Killing Is Not Enough: How Apoptosis Hijacks Tumor-Associated Macrophages to Promote Cancer Progression.

Andreas Weigert1, Javier Mora1, Divya Sekar1, Shahzad Syed1, Bernhard Brüne2.   

Abstract

Macrophages are a group of heterogeneous cells of the innate immune system that are crucial to the initiation, progression, and resolution of inflammation. Moreover, they control tissue homeostasis in healthy tissue and command a broad sensory arsenal to detect disturbances in tissue integrity. Macrophages possess a remarkable functional plasticity to respond to irregularities and to initiate programs that allow overcoming them in order to return back to normal. Thus, macrophages kill malignant or transformed cells, rearrange extracellular matrix, take up and recycle cellular as well as molecular debris, initiate cellular growth cascades, and favor directed migration of cells. As an example, apoptotic death of bystander cells is sensed by macrophages, initiating functional responses that support all hallmarks of cancer. In this chapter, we describe how tumor cell apoptosis hijacks tumor-associated macrophages to promote tumor growth. We propose that tumor therapy should not only kill malignant cells but also target the interaction of the host with apoptotic cancer cells, as this might be efficient to limit the protumor action of apoptotic cells and boost the antitumor potential of macrophages. Leaving the apoptotic cell/macrophage interaction untouched might also limit the benefit of conventional tumor cell apoptosis-focused therapy since surviving tumor cells might receive overwhelming support by the wound healing response that apoptotic tumor cells will trigger in local macrophages, thereby enhancing tumor recurrence.

Entities:  

Keywords:  Apoptotic cells; Hallmarks of cancer; Macrophage polarization; Ontogeny of tumor macrophages; Role of tumor-associated macrophages; Tumor immunosuppression; Tumor stroma interaction; Tumor therapy directed against tumor-associated macrophages; Tumor-associated macrophages

Mesh:

Substances:

Year:  2016        PMID: 27558823     DOI: 10.1007/978-3-319-39406-0_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  17 in total

Review 1.  The Apoptosis Paradox in Cancer.

Authors:  Ornella Morana; Will Wood; Christopher D Gregory
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

Review 2.  S1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1β or Lipocalin-2.

Authors:  Shahzad N Syed; Michaela Jung; Andreas Weigert; Bernhard Brüne
Journal:  Mediators Inflamm       Date:  2017-07-19       Impact factor: 4.711

3.  Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism.

Authors:  Charlotte Dahlem; Wei Xiong Siow; Maria Lopatniuk; William K F Tse; Sonja M Kessler; Susanne H Kirsch; Jessica Hoppstädter; Angelika M Vollmar; Rolf Müller; Andriy Luzhetskyy; Karin Bartel; Alexandra K Kiemer
Journal:  Cancers (Basel)       Date:  2020-05-19       Impact factor: 6.639

4.  Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin.

Authors:  Jaimie Chang; Swati S Bhasin; Diane R Bielenberg; Vikas P Sukhatme; Manoj Bhasin; Sui Huang; Mark W Kieran; Dipak Panigrahy
Journal:  FASEB J       Date:  2018-06-29       Impact factor: 5.191

5.  Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype.

Authors:  Ann-Christin Frank; Stefanie Ebersberger; Annika F Fink; Sebastian Lampe; Andreas Weigert; Tobias Schmid; Ingo Ebersberger; Shahzad Nawaz Syed; Bernhard Brüne
Journal:  Nat Commun       Date:  2019-03-08       Impact factor: 14.919

Review 6.  Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity.

Authors:  Javier Mora; Christina Mertens; Julia K Meier; Dominik C Fuhrmann; Bernhard Brüne; Michaela Jung
Journal:  Cells       Date:  2019-05-11       Impact factor: 6.600

Review 7.  Role of tumor-associated immune cells in prostate cancer: angel or devil?

Authors:  Shui-Qing Wu; Hao Su; Yin-Huai Wang; Xiao-Kun Zhao
Journal:  Asian J Androl       Date:  2019 Sep-Oct       Impact factor: 3.285

Review 8.  MicroRNA-A Tumor Trojan Horse for Tumor-Associated Macrophages.

Authors:  Shahzad Nawaz Syed; Ann-Christin Frank; Rebecca Raue; Bernhard Brüne
Journal:  Cells       Date:  2019-11-21       Impact factor: 6.600

Review 9.  An apoptosis-driven 'onco-regenerative niche': roles of tumour-associated macrophages and extracellular vesicles.

Authors:  Christopher D Gregory; Margaret Paterson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

Review 10.  Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2?

Authors:  Michaela Jung; Andreas Weigert; Christina Mertens; Claudia Rehwald; Bernhard Brüne
Journal:  Front Immunol       Date:  2017-09-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.